BioMarin Pharmaceutical Inc.

776 articles with BioMarin Pharmaceutical Inc.

• BioMarin Pharmaceutical Inc. And Serono, Inc. Announce Positive Results From Phase 3 Clinical Study Of Phenoptin For PKU; Shares Up

  3/16/2006

• BioMarin Pharmaceutical Inc. And ALLIANT Pharmaceuticals, Inc. Announce North American Licensing Agreement For Orapred

  3/16/2006

• BioMarin Pharmaceutical Inc. To Present At SG Cowen & Co., LLC 26th Annual Health Care Conference

  2/28/2006

• BioMarin Pharmaceutical Inc. Announces Fourth Quarter And Year-End 2005 Financial Results

  2/24/2006

• BioMarin Pharmaceutical Inc. to Host Fourth Quarter And Year-End 2005 Earnings Call And Webcast On Thursday, February 23 At 5:00 P.M. ET (23:00 CET)

  2/22/2006

• BioMarin Pharmaceutical Inc. Receives Marketing Approval For Naglazyme In European Union

  1/31/2006

• BioMarin Pharmaceutical Inc. Receives FDA Fast Track Designation For Phenoptin For PKU

  1/26/2006

• BioMarin Pharmaceutical Inc. Establishes Commercial Operations In Europe

  1/11/2006

• BioMarin Pharmaceutical Inc. To Host Research And Development Day On Tuesday, December 6

  11/22/2005

• BioMarin Pharmaceutical Inc. To Present At The SG Cowen & Co., LLC 6th Annual Global Health Care Conference

  11/4/2005

• BioMarin Pharmaceutical Inc. Announces Third Quarter 2005 Financial Results

  11/2/2005

• BioMarin Pharmaceutical Inc. To Present At The Rodman And Renshaw Techvest 7th Annual Healthcare Conference

  11/1/2005

• BioMarin Pharmaceutical Inc. Announces U.S. FDA Acceptance Of Orapred ODT Filing

  10/20/2005

• WeissComm Partners Adds Four New Clients

  10/12/2005

• BioMarin Pharmaceutical Inc. Follows Genzyme Corporation's Playbook

  8/23/2005

• The Day In Review: Biotech Takes First Loss In A Week

  5/5/2005